Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.66 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.50 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.50 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.50 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | ME2 | P23368 | 1/20 | 0.43 |
| ▸ | ME1 | P48163 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3531218 | 0.85 | MIF (0.52) | MIFGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL3843042 | 0.84 | GRIN2D (0.50) | MIFGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL14196061 | 0.84 | GRIN2D (0.50) | MIFGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL24020497 | 0.84 | MIF (0.66) | MIFGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8476286 | 0.84 | CYP2C19 (0.68) | MIFGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL10914051 | 0.83 | CYP2C19 (0.50) | MIFCYP2C19HIF1AMAPTCYP3A4 | |
| SCHEMBL986565 | 0.82 | GRIN2D (0.53) | MIFGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL9076603 | 0.82 | MIF (0.63) | MIFGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL5990790 | 0.82 | ESR1 (0.56) | MIFCYP2C19HIF1ACYP3A4ME2 | |
| SCHEMBL3485439 | 0.82 | CYP2C19 (0.48) | MIFKMT2ACYP2C19HIF1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12486218-B2 | Compounds advantageous in the treatment of central nervous system diseases and disorders | AURIMMED PHARMA, INC. (US) | 2025-12-02 | — | — | US | disclosed |
| US-20240425505-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2024-12-26 | — | — | US | disclosed |
| US-12110290-B2 | Triazolopyridinyl compounds as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-10-08 | — | — | US | disclosed |
| US-20240239739-A1 | COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA, INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240239739-A1 | COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA, INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240239739-A1 | COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA, INC. | 2024-07-18 | — | — | US | disclosed |
| EP-4364737-A2 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-4229056-B1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20240109888-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2024-04-04 | — | — | US | disclosed |
| US-11767322-B2 | Triazolopyridinyl compounds as kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-09-26 | — | — | US | disclosed |
| US-20020061323-A1 | SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-05-23 | — | — | US | disclosed |
| EP-0906014-B1 | Shaped bodies which release agrochemicals | BAYER AG (DE) | 2002-03-27 | — | — | EP | disclosed |
| US-20010039248-A1 | Shaped bodies which release agrochemical active substances | PODSZUN WOLFGANG (DE) | 2001-11-08 | — | — | US | disclosed |
| EP-0564945-B1 | A method of controlling harmful insects | BAYER AGROCHEM KK (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-6063393-A | RODS OR PINS TO BE PRESSED INTO PLANTS | NIHON BAYER AGROCHEM K.K. (JP) | 2000-05-16 | — | — | US | disclosed |
| EP-0906014-A1 | SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES | BAYER AG (DE) | 1999-04-07 | — | — | EP | disclosed |
| EP-0861024-A1 | POLYSACCHARIDE ETHER ESTERS WHICH RELEASE ACTIVE INGREDIENTS | BAYER AG (DE) | 1998-09-02 | — | — | EP | disclosed |
| WO-1997046094-A1 | SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-11 | — | — | WO | disclosed |
| WO-1997017847-A1 | POLYSACCHARIDE ETHER ESTERS WHICH RELEASE ACTIVE INGREDIENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-05-22 | — | — | WO | disclosed |
| EP-0564945-A1 | A method of controlling harmful insects | NIHON BAYER AGROCHEM K.K. (JP) | 1993-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486218-B2 | Compounds advantageous in the treatment of central nervous system diseases and disorders | SMN1; SMN2, HDAC6, CTSA | MIF 1741/4885GRIN2D 94/4885GRIN3B 14/4885 |
| US-20020061323-A1 | SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES | AGL, CHMP4B, GUSB | MIF 3839/4885GRIN2D 4413/4885GRIN3B 4531/4885 |
| US-20010039248-A1 | Shaped bodies which release agrochemical active substances | AGL, CHMP4B, GUSB | MIF 3847/4885GRIN2D 4459/4885GRIN3B 4522/4885 |
| US-20240109888-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | RIPK1, RIPK3, RIPK4 | MIF 1154/4885GRIN2D 1733/4885GRIN3B 1126/4885 |
| US-11767322-B2 | Triazolopyridinyl compounds as kinase inhibitors | RIPK1, RIPK3, RIPK4 | MIF 1154/4885GRIN2D 1733/4885GRIN3B 1126/4885 |
| US-12110290-B2 | Triazolopyridinyl compounds as kinase inhibitors | RIPK1, RIPK3, RIPK4 | MIF 1154/4885GRIN2D 1733/4885GRIN3B 1126/4885 |
| US-20240425505-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | RIPK1, RIPK3, RIPK4 | MIF 1154/4885GRIN2D 1733/4885GRIN3B 1126/4885 |
| US-20240239739-A1 | COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | SMN1; SMN2, HDAC6, CTSA | MIF 1741/4885GRIN2D 94/4885GRIN3B 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.